Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
58.00
Nov 19 • 8:50 AM ET Dollar change+1.05 Percentage change(1.84%)
Index
RUT
Market Cap
3.46B
Enterprise Value
3.13B
Income
-31.92M
Sales
266.93M
Book/sh
8.31
Cash/sh
5.86
Employees
622
IPO
Dec 17, 1986
P/E
-
Forward P/E
82.19
PEG
1.66
P/S
12.98
P/B
6.98
P/C
9.90
P/FCF
157.19
EV/EBITDA
-
EV/Sales
11.74
Quick Ratio
10.67
Current Ratio
12.02
Debt/Eq
0.04
LT Debt/Eq
0.04
Option/Short
Yes / Yes
EPS (ttm)
-0.65
EPS next Y
0.71
EPS next Q
0.15
EPS this Y
91.03%
EPS next Y
27.38%
EPS next 5Y
49.65%
EPS past 3/5Y
20.86% 10.54%
Sales past 3/5Y
17.57% 14.93%
EPS Y/Y TTM
-1274.47%
Sales Y/Y TTM
24.32%
EPS Q/Q
163.19%
Sales Q/Q
26.22%
Insider Own
2.45%
Insider Trans
-6.31%
Inst Own
103.42%
Inst Trans
8.87%
ROA
-8.33%
ROE
-10.35%
ROIC
-6.21%
Gross Margin
74.18%
Oper. Margin
-5.17%
Profit Margin
-11.96%
SMA20
15.03%
SMA50
31.52%
SMA200
41.60%
Trades
Shs Outstand
59.72M
Shs Float
58.27M
52W High
59.72 -2.88%
52W Low
23.61 145.66%
Volatility
4.85% 5.66%
ATR (14)
2.67
RSI (14)
72.06
Beta
1.10
Rel Volume
0.02
Avg Volume
1.58M
Volume
1,271
Perf Week
4.69%
Perf Month
58.99%
Perf Quarter
15.08%
Perf Half Y
40.40%
Perf YTD
77.21%
Perf Year
129.61%
Perf 3Y
886.39%
Perf 5Y
494.26%
Perf 10Y
551.69%
Prev Close
56.95
Price
58.00
Change %
1.84%
Consensus
Strong Buy
Avg. Price Target
$59.27
Implied Upside
+2.2%
Analysts13incl. previous ratings
Rating Distribution11 Buy · 2 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Oct 12, 2026Initiated
BAC logoBBofA Securities
Buy$52-10.3%
Oct 07, 2026Initiated
BCS logoBBarclays
Overweight$55-5.2%
Aug 26, 2026Initiated
TFC logoTTruist
Buy$60+3.4%
Feb 19, 2026Initiated
WFC logoWWells Fargo
Overweight$40-31.0%
Dec 01, 2025Initiated
MFG logoMMizuho
Outperform$40-31.0%
Mar 17, 2025Initiated
LLake Street
Buy$30-48.3%
Jul 01, 2024Initiated
RJF logoRRaymond James
Outperform$13-77.6%
Nov 11, 2022Resumed
JEF logoJJefferies
Buy$15-74.1%
May 09, 2022Upgrade
CCanaccord Genuity
Hold → Buy$10 → $15-74.1%
Mar 11, 2022Resumed
CCantor Fitzgerald
Overweight$21-63.8%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TYNDALL JOSEPH A.DirectorSep 02 '26Sale49.703,500173,94010,650Sep 04 04:08 PM
JOSEPH A TYNDALLDirectorSep 02 '26Proposed Sale49.883,500174,580Sep 02 04:32 PM
Began Marc AEVP & General CounselAug 10 '26Option Exercise8.1667,500550,800117,635Aug 12 04:13 PM
Began Marc AEVP & General CounselAug 10 '26Sale47.3467,5003,195,78850,135Aug 12 04:13 PM
Wendell Amy McBrideDirectorAug 11 '26Option Exercise14.8513,353198,292121,329Aug 12 04:12 PM
Wendell Amy McBrideDirectorAug 11 '26Sale48.4213,353646,592107,976Aug 12 04:12 PM
AMY MCBRIDE-WENDELLDirectorAug 11 '26Proposed Sale48.2213,353643,882Aug 11 04:29 PM
Weiler Kathy JohnsonDirectorAug 07 '26Sale45.3014,150640,9670Aug 11 04:15 PM
MARC BEGANOfficerAug 10 '26Proposed Sale46.4367,5003,134,025Aug 10 04:32 PM
KATHY WEILERDirectorAug 07 '26Proposed Sale44.3514,150627,552Aug 07 04:37 PM
Levine Alan MDirectorJun 19 '26Option Exercise0.0014,150050,893Jun 23 04:37 PM
Weiler Kathy JohnsonDirectorJun 19 '26Option Exercise0.0014,150014,150Jun 23 04:37 PM
Wendell Amy McBrideDirectorJun 19 '26Option Exercise0.0014,1500107,976Jun 23 04:36 PM
THOMAS PAULDirectorJun 19 '26Option Exercise0.0018,867032,395Jun 23 04:36 PM
TYNDALL JOSEPH A.DirectorJun 19 '26Option Exercise0.0014,150014,150Jun 23 04:36 PM
JOHNSON JOHNDirectorJun 19 '26Option Exercise0.0014,150014,150Jun 23 04:35 PM
Burke William P. Mr.DirectorJun 19 '26Option Exercise0.0014,150014,250Jun 23 04:35 PM
Wendell Amy McBrideDirectorMay 08 '26Option Exercise14.851,64724,45895,473May 12 04:06 PM
Wendell Amy McBrideDirectorMay 08 '26Sale42.601,64770,16293,826May 12 04:06 PM
AMY MCBRIDE-WENDELLDirectorMay 08 '26Proposed Sale42.601,64770,163May 08 04:40 PM
JOHNSON JOHNDirectorMay 07 '26Option Exercise7.0411,05077,79211,050May 08 04:07 PM
JOHNSON JOHNDirectorMay 07 '26Sale43.2611,050477,9680May 08 04:07 PM
Weiler Kathy JohnsonDirectorMay 07 '26Option Exercise6.9516,344113,59116,344May 08 04:07 PM
Weiler Kathy JohnsonDirectorMay 07 '26Sale44.0916,344720,6230May 08 04:07 PM
Kemp JensChief Marketing OfficerMay 07 '26Sale43.444,000173,76172,451May 08 04:07 PM
Hartley Lindsey MarieCFOMay 07 '26Option Exercise8.245,46345,00465,719May 08 04:06 PM
Hartley Lindsey MarieCFOMay 07 '26Sale43.671,05145,89762,756May 08 04:06 PM
Quackenbush DorisSales VPMay 07 '26Sale43.513,878168,72092,416May 08 04:06 PM
JOHN H JOHNSONDirectorMay 07 '26Proposed Sale43.2611,050477,971May 07 05:26 PM
DORIS QUACKENBUSHVice President of SalesMay 07 '26Proposed Sale43.513,878168,719May 07 04:47 PM
JENS KEMPOfficerMay 07 '26Proposed Sale43.444,000173,761May 07 04:05 PM
KATHY WEILERDirectorMay 07 '26Proposed Sale44.0916,344720,630May 07 04:05 PM
DeVinney Erick WayneChief Innovation OfficerMar 16 '26Option Exercise0.0017,9380268,002Mar 18 04:11 PM
DeVinney Erick WayneChief Innovation OfficerMar 16 '26Sale32.845,221171,458262,781Mar 18 04:11 PM
Hartley Lindsey MarieCFOMar 16 '26Option Exercise0.009,000062,702Mar 18 04:10 PM
Began Marc AEVP & General CounselMar 01 '26Option Exercise0.0011,250054,562Mar 02 06:15 PM
Wendell Amy McBrideDirectorDec 16 '25Option Exercise6.9143,684301,963137,510Dec 17 04:25 PM
Wendell Amy McBrideDirectorDec 16 '25Sale29.3143,6841,280,46593,826Dec 17 04:25 PM
Weiler Kathy JohnsonDirectorDec 16 '25Option Exercise6.9940,073280,15046,653Dec 17 04:25 PM
Weiler Kathy JohnsonDirectorDec 16 '25Sale29.5546,6531,378,4760Dec 17 04:25 PM
Hartley Lindsey MarieCFODec 15 '25Option Exercise8.2714,812122,49546,188Dec 17 04:24 PM
Hartley Lindsey MarieCFODec 15 '25Sale29.8614,812442,29431,376Dec 17 04:24 PM
Amy McBride-WendellDirectorDec 16 '25Proposed Sale29.3143,6841,280,461Dec 16 05:03 PM
KATHY WEILERDirectorDec 16 '25Proposed Sale29.5546,6531,378,484Dec 16 04:27 PM
LINDSEY MARIE HARTLEYOfficerDec 15 '25Proposed Sale29.8614,812442,294Dec 15 05:38 PM
DALE MICHAEL DChief Executive OfficerDec 10 '25Sale30.0025,000750,00063,537Dec 12 04:06 PM
Began Marc AEVP & General CounselDec 11 '25Sale30.0013,222396,66018,285Dec 12 04:05 PM
MARC BEGANOfficerDec 11 '25Proposed Sale30.0013,222396,660Dec 11 04:08 PM
DALE MICHAEL DChief Executive OfficerDec 09 '25Sale31.2161,4631,918,13788,537Dec 10 05:21 PM
TYNDALL JOSEPH A.DirectorDec 09 '25Option Exercise8.7325,108219,22325,108Dec 10 05:20 PM
TYNDALL JOSEPH A.DirectorDec 09 '25Sale30.9825,108777,7710Dec 10 05:20 PM
DeVinney Erick WayneChief Innovation OfficerDec 09 '25Sale31.2119,517609,087241,132Dec 10 05:20 PM
Kemp JensChief Marketing OfficerDec 09 '25Sale31.218,156254,53246,030Dec 10 05:20 PM
Began Marc AEVP & General CounselDec 09 '25Sale31.219,278289,54831,507Dec 10 05:19 PM
THOMAS PAULDirectorDec 09 '25Sale29.6121,399633,71013,528Dec 10 05:19 PM
JOHNSON JOHNDirectorDec 08 '25Option Exercise6.3011,89174,91325,032Dec 10 05:19 PM
JOHNSON JOHNDirectorDec 09 '25Option Exercise6.308,54553,83421,686Dec 10 05:19 PM
JOHNSON JOHNDirectorDec 08 '25Sale31.2423,693740,20313,141Dec 10 05:19 PM
JOHNSON JOHNDirectorDec 09 '25Sale29.9821,686650,1900Dec 10 05:19 PM
Hartley Lindsey MarieCFODec 08 '25Option Exercise13.8225,000345,40045,763Dec 10 05:18 PM
Hartley Lindsey MarieCFODec 08 '25Sale31.5614,387454,00531,376Dec 10 05:18 PM
MICHAEL DALEOfficerDec 10 '25Proposed Sale30.0025,000750,000Dec 10 04:19 PM
PAUL THOMASDirectorDec 09 '25Proposed Sale29.6121,399633,710Dec 09 04:40 PM
JOSEPH A TYNDALLDirectorDec 09 '25Proposed Sale30.9825,108777,771Dec 09 04:39 PM
JOHN H JOHNSONDirectorDec 09 '25Proposed Sale29.9821,686650,186Dec 09 04:05 PM
JOHN H JOHNSONDirectorDec 08 '25Proposed Sale31.2423,693740,207Dec 08 06:21 PM
LINDSEY MARIE HARTLEYOfficerDec 08 '25Proposed Sale31.5614,387454,009Dec 08 04:32 PM
Axogen, Inc. engages in the development and marketing of surgical solutions for peripheral nerve regeneration and repair. It provides products and educational resources to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Avive Soft Tissue Membrane, AcroVal Neurosensory and Motor Testing System, and AxoTouch Two-Point Discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.
PresidentMr. Michael D. Dale
Chief Financial OfficerMs. Lindsey Hartley CPA
Chief Scientific OfficerMr. Erick DeVinney
Executive VPMr. Marc A. Began
Chief Marketing OfficerMr. Jens Schroeder Kemp